Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross
Tags :Ex-Featured
Oc Oerlikon corporation has acquired Coeurdor, a full-service provider of components for the luxury goods industry, from Riri Group. This acquisition allows Oerlikon – according to a press release – to expand its product range and offer
The 2021 Wolters Kluwer Future Ready Lawyer Survey: Moving Beyond the Pandemic includes insights from 700 legal professionals across nine European countries and the U.S. The survey examines issues and trends affecting the future of law
Froriep acted as legal counsel to VanEck ETP and VanEck (Europe) in the launch of the VanEck Vectors Exchange Traded Notes Program at SIX. Froriep advised VanEck on the entire listing process for the multicurrency
Walder Wyss acted as legal counsel to Alentis Therapeutics on the USD 67 million series B financing round. Morningside Venture Investments led the financing, joined by Jeito Capital and Series A investors Biomed Partners, BB Pureos
The Heubach Group, in partnership with Sk Capital, announced today a definitive agreement to acquire Clariant’s pigments business. The combined business will operate under the Heubach name, creating a global pigments leader generating more
Colfax Corporation subsidiary DJO, has entered into a definitive agreement to expand DJO’s reconstructive business and acquire Mathys Bettlach (Mathys). Mathys shareholders have approved the sale of all shares to the mother company of
In the context of Swiss Steel Holding’s 2020 recapitalization, the Financial Market Supervisory Authority FINMA had granted BigPoint Holding and its sole shareholder Martin Haefner an exemption from the mandatory tender duty. In January 2021, Liwet
Adrian Wyss (pictured) joins Bratschi as new partner effective from 1 June 2021. Adrian Wyss has long-standing consultancy and litigation experience in the field of intellectual property law, in particular trademark law, copyright and design law, unfair
Mérieux Equity Partners, France (MxEP) has agreed to invest EUR 40 million into Swixx Biopharma, Switzerland (Swixx), taking a minority position. SIX listed HBM Healthcare Investments who had invested in Swixx in 2017, will co-invest alongside
